Global IBS-C Drugs Market Size, Status and Forecast 2025 - Garner Insights

Global IBS-C Drugs Market Size, Status and Forecast 2025

ID: 317595 04/07/2018 Region : Global 101 Pages QY RESEARCH

This report studies the global IBS-C Drugs market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global IBS-C Drugs market by companies, region, type and end-use industry. In 2017, the global IBS-C Drugs market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025. This report focuses on the global top players, covered Catalent Pharmaceuticals Solutions Nestle Abbott Laboratories Synergy Pharmaceuticals Sucampo Pharmaceuticals Novartis Pharma Ag Astellas Pharmaceuticals Ardelyx, Inc Synthetic Biologics, Inc Teva Pharmaceutical Industries Bama-Geve, SLU Ferring BV Ironwood Pharmaceuticals, Inc Salix Pharmaceuticals Ltd Norgine B.V Prometheus Laboratories Inc Actavis Nordic A/S Albireo Pharma Inc Yuhan Corp Astrazeneca Plc The Menarini Group Ono Pharmaceutical Co., Ltd Market segment by Regions/Countries, this report covers United States Europe China Japan Southeast Asia India Market segment by Type, the product can be split into Linaclotide Lubiprostone Osmotic Laxatives Stimulant Laxatives Other Market segment by Application, split into Hospital Pharmacies Retail Pharmacies Online Pharmacies The study objectives of this report are: To study and forecast the market size of IBS-C Drugs in global market. To analyze the global key players, SWOT analysis, value and global market share for top players. To define, describe and forecast the market by type, end use and region. To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World. To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks. To identify significant trends and factors driving or inhibiting the market growth. To analyze the opportunities in the market for stakeholders by identifying the high growth segments. To strategically analyze each submarket with respect to individual growth trend and their contribution to the market To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market To strategically profile the key players and comprehensively analyze their growth strategies. In this study, the years considered to estimate the market size of IBS-C Drugs are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered. Key Stakeholders IBS-C Drugs Manufacturers IBS-C Drugs Distributors/Traders/Wholesalers IBS-C Drugs Subcomponent Manufacturers Industry Association Downstream Vendors Available Customizations With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report: Regional and country-level analysis of the IBS-C Drugs market, by end-use. Detailed analysis and profiles of additional market players.

Table of Contents Global IBS-C Drugs Market Size, Status and Forecast 2025 1 Industry Overview of IBS-C Drugs 1.1 IBS-C Drugs Market Overview 1.1.1 IBS-C Drugs Product Scope 1.1.2 Market Status and Outlook 1.2 Global IBS-C Drugs Market Size and Analysis by Regions (2013-2018) 1.2.1 United States 1.2.2 Europe 1.2.3 China 1.2.4 Japan 1.2.5 Southeast Asia 1.2.6 India 1.3 IBS-C Drugs Market by Type 1.3.1 Linaclotide 1.3.2 Lubiprostone 1.3.3 Osmotic Laxatives 1.3.4 Stimulant Laxatives 1.3.5 Other 1.4 IBS-C Drugs Market by End Users/Application 1.4.1 Hospital Pharmacies 1.4.2 Retail Pharmacies 1.4.3 Online Pharmacies 2 Global IBS-C Drugs Competition Analysis by Players 2.1 IBS-C Drugs Market Size (Value) by Players (2013-2018) 2.2 Competitive Status and Trend 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 New Entrants 2.2.4 The Technology Trends in Future 3 Company (Top Players) Profiles 3.1 Catalent Pharmaceuticals Solutions 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 IBS-C Drugs Revenue (Million USD) (2013-2018) 3.2 Nestle 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 IBS-C Drugs Revenue (Million USD) (2013-2018) 3.3 Abbott Laboratories 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 IBS-C Drugs Revenue (Million USD) (2013-2018) 3.4 Synergy Pharmaceuticals 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 IBS-C Drugs Revenue (Million USD) (2013-2018) 3.5 Sucampo Pharmaceuticals 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 IBS-C Drugs Revenue (Million USD) (2013-2018) 3.6 Novartis Pharma Ag 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 IBS-C Drugs Revenue (Million USD) (2013-2018) 3.7 Astellas Pharmaceuticals 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 IBS-C Drugs Revenue (Million USD) (2013-2018) 3.8 Ardelyx, Inc 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 IBS-C Drugs Revenue (Million USD) (2013-2018) 3.9 Synthetic Biologics, Inc 3.9.1 Company Profile 3.9.2 Main Business/Business Overview 3.9.3 Products, Services and Solutions 3.9.4 IBS-C Drugs Revenue (Million USD) (2013-2018) 3.10 Teva Pharmaceutical Industries 3.10.1 Company Profile 3.10.2 Main Business/Business Overview 3.10.3 Products, Services and Solutions 3.10.4 IBS-C Drugs Revenue (Million USD) (2013-2018) 3.11 Bama-Geve, SLU 3.12 Ferring BV 3.13 Ironwood Pharmaceuticals, Inc 3.14 Salix Pharmaceuticals Ltd 3.15 Norgine B.V 3.16 Prometheus Laboratories Inc 3.17 Actavis Nordic A/S 3.18 Albireo Pharma Inc 3.19 Yuhan Corp 3.20 Astrazeneca Plc 3.21 The Menarini Group 3.22 Ono Pharmaceutical Co., Ltd 4 Global IBS-C Drugs Market Size by Type and Application (2013-2018) 4.1 Global IBS-C Drugs Market Size by Type (2013-2018) 4.2 Global IBS-C Drugs Market Size by Application (2013-2018) 4.3 Potential Application of IBS-C Drugs in Future 4.4 Top Consumer/End Users of IBS-C Drugs 5 United States IBS-C Drugs Development Status and Outlook 5.1 United States IBS-C Drugs Market Size (2013-2018) 5.2 United States IBS-C Drugs Market Size and Market Share by Players (2013-2018) 5.3 United States IBS-C Drugs Market Size by Application (2013-2018) 6 Europe IBS-C Drugs Development Status and Outlook 6.1 Europe IBS-C Drugs Market Size (2013-2018) 6.2 Europe IBS-C Drugs Market Size and Market Share by Players (2013-2018) 6.3 Europe IBS-C Drugs Market Size by Application (2013-2018) 7 China IBS-C Drugs Development Status and Outlook 7.1 China IBS-C Drugs Market Size (2013-2018) 7.2 China IBS-C Drugs Market Size and Market Share by Players (2013-2018) 7.3 China IBS-C Drugs Market Size by Application (2013-2018) 8 Japan IBS-C Drugs Development Status and Outlook 8.1 Japan IBS-C Drugs Market Size (2013-2018) 8.2 Japan IBS-C Drugs Market Size and Market Share by Players (2013-2018) 8.3 Japan IBS-C Drugs Market Size by Application (2013-2018) 9 Southeast Asia IBS-C Drugs Development Status and Outlook 9.1 Southeast Asia IBS-C Drugs Market Size (2013-2018) 9.2 Southeast Asia IBS-C Drugs Market Size and Market Share by Players (2013-2018) 9.3 Southeast Asia IBS-C Drugs Market Size by Application (2013-2018) 10 India IBS-C Drugs Development Status and Outlook 10.1 India IBS-C Drugs Market Size (2013-2018) 10.2 India IBS-C Drugs Market Size and Market Share by Players (2013-2018) 10.3 India IBS-C Drugs Market Size by Application (2013-2018) 11 Market Forecast by Regions, Type and Application (2018-2025) 11.1 Global IBS-C Drugs Market Size (Value) by Regions (2018-2025) 11.1.1 United States IBS-C Drugs Revenue and Growth Rate (2018-2025) 11.1.2 Europe IBS-C Drugs Revenue and Growth Rate (2018-2025) 11.1.3 China IBS-C Drugs Revenue and Growth Rate (2018-2025) 11.1.4 Japan IBS-C Drugs Revenue and Growth Rate (2018-2025) 11.1.5 Southeast Asia IBS-C Drugs Revenue and Growth Rate (2018-2025) 11.1.6 India IBS-C Drugs Revenue and Growth Rate (2018-2025) 11.2 Global IBS-C Drugs Market Size (Value) by Type (2018-2025) 11.3 Global IBS-C Drugs Market Size by Application (2018-2025) 12 IBS-C Drugs Market Dynamics 12.1 IBS-C Drugs Market Opportunities 12.2 IBS-C Drugs Challenge and Risk 12.2.1 Competition from Opponents 12.2.2 Downside Risks of Economy 12.3 IBS-C Drugs Market Constraints and Threat 12.3.1 Threat from Substitute 12.3.2 Government Policy 12.3.3 Technology Risks 12.4 IBS-C Drugs Market Driving Force 12.4.1 Growing Demand from Emerging Markets 12.4.2 Potential Application 13 Market Effect Factors Analysis 13.1 Technology Progress/Risk 13.1.1 Substitutes 13.1.2 Technology Progress in Related Industry 13.2 Consumer Needs Trend/Customer Preference 13.3 External Environmental Change 13.3.1 Economic Fluctuations 13.3.2 Other Risk Factors 14 Research Finding/Conclusion 15 Appendix Methodology Analyst Introduction Data Source

List of Tables and Figures Figure Global IBS-C Drugs Market Size (Million USD) Status and Outlook (2013-2018) Table Global IBS-C Drugs Revenue (Million USD) Comparison by Regions (2013-2018) Figure Global IBS-C Drugs Market Share by Regions (2013-2018) Figure United States IBS-C Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018) Figure Europe IBS-C Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018) Figure China IBS-C Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018) Figure Japan IBS-C Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018) Figure Southeast Asia IBS-C Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018) Figure India IBS-C Drugs Market Size (Million USD) and Growth Rate by Regions (2013-2018) Table Global IBS-C Drugs Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018) Figure Global IBS-C Drugs Revenue Market Share by Type in 2017 Figure Linaclotide Market Size (Million USD) and Growth Rate (2013-2018) Figure Lubiprostone Market Size (Million USD) and Growth Rate (2013-2018) Figure Osmotic Laxatives Market Size (Million USD) and Growth Rate (2013-2018) Figure Stimulant Laxatives Market Size (Million USD) and Growth Rate (2013-2018) Figure Other Market Size (Million USD) and Growth Rate (2013-2018) Figure Global IBS-C Drugs Market Share by Application in 2017 Figure IBS-C Drugs Market Size (Million USD) and Growth Rate in Hospital Pharmacies (2013-2018) Figure IBS-C Drugs Market Size (Million USD) and Growth Rate in Retail Pharmacies (2013-2018) Figure IBS-C Drugs Market Size (Million USD) and Growth Rate in Online Pharmacies (2013-2018) Table IBS-C Drugs Market Size (Million USD) by Players (2013-2018) Figure IBS-C Drugs Market Size Share by Players in 2013 Figure IBS-C Drugs Market Size Share by Players in 2017 Table Catalent Pharmaceuticals Solutions Basic Information List Table IBS-C Drugs Business Revenue (Million USD) of Catalent Pharmaceuticals Solutions (2013-2018) Figure Catalent Pharmaceuticals Solutions IBS-C Drugs Business Revenue Market Share (2013-2018) Table Nestle Basic Information List Table IBS-C Drugs Business Revenue (Million USD) of Nestle (2013-2018) Figure Nestle IBS-C Drugs Business Revenue Market Share (2013-2018) Table Abbott Laboratories Basic Information List Table IBS-C Drugs Business Revenue (Million USD) of Abbott Laboratories (2013-2018) Figure Abbott Laboratories IBS-C Drugs Business Revenue Market Share (2013-2018) Table Synergy Pharmaceuticals Basic Information List Table IBS-C Drugs Business Revenue (Million USD) of Synergy Pharmaceuticals (2013-2018) Figure Synergy Pharmaceuticals IBS-C Drugs Business Revenue Market Share (2013-2018) Table Sucampo Pharmaceuticals Basic Information List Table IBS-C Drugs Business Revenue (Million USD) of Sucampo Pharmaceuticals (2013-2018) Figure Sucampo Pharmaceuticals IBS-C Drugs Business Revenue Market Share (2013-2018) Table Novartis Pharma Ag Basic Information List Table IBS-C Drugs Business Revenue (Million USD) of Novartis Pharma Ag (2013-2018) Figure Novartis Pharma Ag IBS-C Drugs Business Revenue Market Share (2013-2018) Table Astellas Pharmaceuticals Basic Information List Table IBS-C Drugs Business Revenue (Million USD) of Astellas Pharmaceuticals (2013-2018) Figure Astellas Pharmaceuticals IBS-C Drugs Business Revenue Market Share (2013-2018) Table Ardelyx, Inc Basic Information List Table IBS-C Drugs Business Revenue (Million USD) of Ardelyx, Inc (2013-2018) Figure Ardelyx, Inc IBS-C Drugs Business Revenue Market Share (2013-2018) Table Synthetic Biologics, Inc Basic Information List Table IBS-C Drugs Business Revenue (Million USD) of Synthetic Biologics, Inc (2013-2018) Figure Synthetic Biologics, Inc IBS-C Drugs Business Revenue Market Share (2013-2018) Table Teva Pharmaceutical Industries Basic Information List Table IBS-C Drugs Business Revenue (Million USD) of Teva Pharmaceutical Industries (2013-2018) Figure Teva Pharmaceutical Industries IBS-C Drugs Business Revenue Market Share (2013-2018) Table Bama-Geve, SLU Basic Information List Table IBS-C Drugs Business Revenue (Million USD) of Bama-Geve, SLU (2013-2018) Figure Bama-Geve, SLU IBS-C Drugs Business Revenue Market Share (2013-2018) Table Ferring BV Basic Information List Table IBS-C Drugs Business Revenue (Million USD) of Ferring BV (2013-2018) Figure Ferring BV IBS-C Drugs Business Revenue Market Share (2013-2018) Table Ironwood Pharmaceuticals, Inc Basic Information List Table Salix Pharmaceuticals Ltd Basic Information List Table Norgine B.V Basic Information List Table Prometheus Laboratories Inc Basic Information List Table Actavis Nordic A/S Basic Information List Table Albireo Pharma Inc Basic Information List Table Yuhan Corp Basic Information List Table Astrazeneca Plc Basic Information List Table The Menarini Group Basic Information List Table Ono Pharmaceutical Co., Ltd Basic Information List Table Global IBS-C Drugs Market Size (Million USD) by Product (2013-2018) Figure Global IBS-C Drugs Revenue Market Share (%) by Product (2013-2018) Figure Global IBS-C Drugs Market Share by Product in 2017 Table Global IBS-C Drugs Market Size by Application (2013-2018) Figure Global IBS-C Drugs Revenue Market Share (%) by Application in 2017 Table Top Consumer/End Users of IBS-C Drugs Figure United States IBS-C Drugs Market Size (Million USD) and Growth Rate (2013-2018) Table United States IBS-C Drugs Market Size (Million USD) by Players (2013-2018) Figure United States IBS-C Drugs Market Size Share by Players in 2013 Figure United States IBS-C Drugs Market Size Share by Players in 2017 Table United States IBS-C Drugs Market Size by Application (2013-2018) Figure United States IBS-C Drugs Revenue Market Share (%) by Application (2013-2018) Figure United States IBS-C Drugs Market Size Share by Application in 2017 Figure Europe IBS-C Drugs Market Size (Million USD) and Growth Rate (2013-2018) Table Europe IBS-C Drugs Market Size (Million USD) by Players (2013-2018) Figure Europe IBS-C Drugs Market Size Share by Players in 2013 Figure Europe IBS-C Drugs Market Size Share by Players in 2017 Table Europe IBS-C Drugs Market Size by Application (2013-2018) Figure Europe IBS-C Drugs Revenue Market Share (%) by Application (2013-2018) Figure Europe IBS-C Drugs Market Size Share by Application in 2017 Figure China IBS-C Drugs Market Size (Million USD) and Growth Rate (2013-2018) Table China IBS-C Drugs Market Size (Million USD) by Players (2013-2018) Figure China IBS-C Drugs Market Size Share by Players in 2013 Figure China IBS-C Drugs Market Size Share by Players in 2017 Table China IBS-C Drugs Market Size by Application (2013-2018) Figure China IBS-C Drugs Revenue Market Share (%) by Application (2013-2018) Figure China IBS-C Drugs Market Size Share by Application in 2017 Figure Japan IBS-C Drugs Market Size (Million USD) and Growth Rate (2013-2018) Table Japan IBS-C Drugs Market Size (Million USD) by Players (2013-2018) Figure Japan IBS-C Drugs Market Size Share by Players in 2013 Figure Japan IBS-C Drugs Market Size Share by Players in 2017 Table Japan IBS-C Drugs Market Size by Application (2013-2018) Figure Japan IBS-C Drugs Revenue Market Share (%) by Application (2013-2018) Figure Japan IBS-C Drugs Market Size Share by Application in 2017 Figure Southeast Asia IBS-C Drugs Market Size (Million USD) and Growth Rate (2013-2018) Table Southeast Asia IBS-C Drugs Market Size (Million USD) by Players (2013-2018) Figure Southeast Asia IBS-C Drugs Market Size Share by Players in 2013 Figure Southeast Asia IBS-C Drugs Market Size Share by Players in 2017 Table Southeast Asia IBS-C Drugs Market Size by Application (2013-2018) Figure Southeast Asia IBS-C Drugs Revenue Market Share (%) by Application (2013-2018) Figure Southeast Asia IBS-C Drugs Market Size Share by Application in 2017 Figure India IBS-C Drugs Market Size (Million USD) and Growth Rate (2013-2018) Table India IBS-C Drugs Market Size (Million USD) by Players (2013-2018) Figure India IBS-C Drugs Market Size Share by Players in 2013 Figure India IBS-C Drugs Market Size Share by Players in 2017 Table India IBS-C Drugs Market Size by Application (2013-2018) Figure India IBS-C Drugs Revenue Market Share (%) by Application (2013-2018) Figure India IBS-C Drugs Market Size Share by Application in 2017 Figure Global IBS-C Drugs Market Size and Growth Rate (2018-2025) Table Global IBS-C Drugs Market Size (Million USD) by Regions (2018-2025) Figure Global IBS-C Drugs Market Size Share (2018-2025) Figure Global IBS-C Drugs Market Size Share by Regions in 2025 Figure United States IBS-C Drugs Revenue (Million USD) and Growth Rate (2018-2025) Figure Europe IBS-C Drugs Revenue (Million USD) and Growth Rate (2018-2025) Figure China IBS-C Drugs Revenue (Million USD) and Growth Rate (2018-2025) Figure Japan IBS-C Drugs Revenue (Million USD) and Growth Rate (2018-2025) Figure Southeast Asia IBS-C Drugs Revenue (Million USD) and Growth Rate (2018-2025) Figure India IBS-C Drugs Revenue (Million USD) and Growth Rate (2018-2025) Table Global IBS-C Drugs Market Size (Million USD) by Type (2018-2025) Figure Global IBS-C Drugs Market Size Share by Type in 2018 Figure Global IBS-C Drugs Market Size Share by Type in 2025 Table Global IBS-C Drugs Market Size (Million USD) by Application (2018-2025) Figure Global IBS-C Drugs Market Size (Million USD) by Application in 2018

Request Sample

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Request Discount

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Related Reports




Get 15 minutes of free Consultation When you request a Sample Report!

24/7 Research Report

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone:

+1 513 549 5911 (US)

+44 203 318 2846 (UK)

Email: [email protected]